Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
CONCLUSIONS: Significant age-related differences in clinical and biochemical profiles exist among PCOS patients, along with insulin resistance status. Early identification of metabolic risks is crucial for timely intervention.
Published on: Fri, 10 Oct 2025 06:00:00 -0400
Authors: Bakht Babar, Ghulam Farooq, Misbah Manzoor, Hashim Khan,
CONCLUSION: High AMH levels associated with the genetic variant (rs10407022) of AMH suggest role of AMH gene dysregulation in the manifestation of PCOS.
Published on: Fri, 10 Oct 2025 06:00:00 -0400
Authors: Laiba Rehmat, Samar Zaki, Haq Nawaz Khan, Unab I Khan, Rehana Rehman,
Polycystic ovary syndrome (PCOS) is a prevalent disorder in the modern world, affecting around 6%-20% of females of childbearing age. Hormonal and metabolic symptoms vary over time but often arise throughout puberty. Treatment includes lifestyle interventions as a first line of treatment. In certain cases, specific medications may be considered. However, there is a growing interest in using Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) in PCOS due to their efficacy in weight loss, insulin...
Published on: Fri, 10 Oct 2025 06:00:00 -0400
Authors: Bassel H Hoteit, Jana Kotaich, Hadi Ftouni, Fatima Hazime, Abdallah Safawi, Rim Masri, Mia Marwani,
CONCLUSION: Chromium picolinate supplementation at a dosage of 200μg may provide benefits similar to metformin with regard to FBG, FBI, ovulation, and pregnancy incidence, with fewer side effects in patients with PCOS. Further experiments are still required to draw effective dietary guidelines related to chromium.
Published on: Thu, 09 Oct 2025 06:00:00 -0400
Authors: Mohammed Hamsho, Yazan Ranneh, Abdulmannan Fadel,
Polycystic ovary syndrome (PCOS) is an endocrine condition affecting women of reproductive age, characterized by hyperandrogenism, ovulatory dysfunction, and some metabolic disturbances. Emerging evidence has been suggesting a link between certain endocrine-disrupting chemicals (EDCs), such as bisphenol A (BPA) and phthalates, and the pathogenesis and/or exacerbation of PCOS. These exogenous compounds interfere with hormonal function, potentially inducing epigenetic modifications and disrupting...
Published on: Thu, 09 Oct 2025 06:00:00 -0400
Authors: Adèle Lemogne Robert, Edite Oliveira Torres, Catarina Jota Baptista,
A review of advancements in primordial follicle activation and cyclic recruitment research over the past 25 years is presented. The review examines the latest insights into the mechanisms of primordial follicle activation and the role of the ovarian Hippo signalling pathways, highlighting their potential for developing new infertility treatments. The concept of continuous waves of early antral follicles and their availability for cyclic recruitment is discussed. Several previously unresolved...
Published on: Thu, 09 Oct 2025 06:00:00 -0400
Authors: Sezcan Mumusoglu, Qingling Yang, Kazuhiro Kawamura, Chialin Chang M, Kui Liu, Aaron J Hsueh,
Polycystic ovary syndrome (PCOS) is a prevalent endocrine-metabolic disorder affecting reproductive-aged women and is characterized by hyperandrogenemia, ovulatory dysfunction, and polycystic ovaries. Astragaloside IV (AS-IV), an active compound derived from Astragalus membranaceus, shows promise in the treatment of metabolic disorders. However, the precise molecular targets and mechanisms of action in PCOS remain unclear. This study aimed to elucidate the therapeutic effects and underlying...
Published on: Thu, 09 Oct 2025 06:00:00 -0400
Authors: Ying Feng, Lei Wu, Jianrong Liu,
CONCLUSION: High prevalence of breast carcinoma cases in women aged 31-50 years highlights shifting trend in its diagnosis. Nearly 80% of breast cancer patients had PCOS, suggesting its influence on tumor biology. Notable prevalence of nutritional deficiency (Vitamin D, serum iron, serum iodine, and folic acid deficiency) warrants further investigation into their role in breast cancer pathogenesis.
Published on: Thu, 09 Oct 2025 06:00:00 -0400
Authors: Mahendra Wante, Ankireddypalle Shanmukha Shashank Reddy, Dakshayani Satish Nirhale, Kishore Jeughale, A Kavya,
Follicular atresia is a critical physiological process that ensures the selection of high-quality oocytes by eliminating non-viable follicles. In women, 99.9% of follicles undergo atresia naturally, the premature or dysregulated atresia follicle can lead to pathological conditions such as polycystic ovary syndrome (PCOS) and premature ovarian failure (POF). Recent studies highlight the roles of apoptosis, autophagy, and ferroptosis in regulating follicular atresia. This review integrates...
Published on: Thu, 09 Oct 2025 06:00:00 -0400
Authors: Tongqing Zhang, Menghan Lin, Chuangui Wang, Jiaqi Zhou,
Pyroptosis is a pathogenenic mechanism of polycystic ovary syndrome (PCOS). N5-methylcytosine (m5C) methylation is a RNA modification that affects the progression of diseases. However, its role in PCOS remains not understood. This study aimed to investigate the role of NSUN7 in PCOS, particularly its impact on pyroptosis. KGN cells were treated with LPS to establish a cell model, and pyroptosis was evaluated using enzyme-linked immunosorbent assay, flow cytometry, and western blotting. The...
Published on: Wed, 08 Oct 2025 06:00:00 -0400
Authors: Guobin Xu, Junlong Wang, Na Gu, Tiansong Yang,
ABSTRACT: Oocyte in vitro maturation (IVM) is an evolving component of assisted reproductive technology (ART) that offers a less invasive and cost-effective alternative to conventional controlled ovarian stimulation. It is particularly beneficial for patients at risk of ovarian hyperstimulation syndrome (OHSS), those with polycystic ovary syndrome (PCOS), and individuals requiring urgent fertility preservation. Despite these advantages, clinical uptake has remained limited owing to concerns...
Published on: Wed, 08 Oct 2025 06:00:00 -0400
Authors: Meiju Liu, Jie Cui, Hsun-Ming Chang, Jing Liu, Peter C K Leung,
CONCLUSIONS: This study demonstrates significantly higher levels of LAP and VAI in patients with PCOS compared to controls. These readily calculable indices may serve as practical tools for metabolic risk stratification in PCOS populations. However, further research is needed to establish their diagnostic accuracy and validate their clinical utility.
Published on: Tue, 07 Oct 2025 06:00:00 -0400
Authors: Mohammadamin Parsaei, Elaheh Karimi, Amirali Barkhordarioon, Mohammadreza Yousefi, Azadeh Tarafdari,
CONCLUSIONS: The prediction model developed in this study is effective for predicting preterm birth risk in ART pregnancies. This model can help clinicians identify high-risk pregnancies early and implement targeted interventions. Cervical length monitoring may be a useful tool in predicting preterm birth, especially after the second trimester.
Published on: Tue, 07 Oct 2025 06:00:00 -0400
Authors: Zhaorui Wang, Hanjie Mo, Liqiong Zhu, Jing Tang, Jia Huang, Zhuoyao Mai, Xuedan Jiao, Menglan Zhu, Xiaohui Ji, Nengyong Ouyang, Hui Chen,
Circular RNAs (circRNAs), a newly recognized category of non-coding RNA, have recently become a central point of interest in biological research. The ovaries are critical reproductive organs in female mammals, profoundly influencing fertility through their effects on endocrine functions and follicular cycle activities. Follicle development, as the fundamental functional component of the ovaries, is elaborately regulated by granulosa cells, oocytes, and endocrine signals. Recent research has...
Published on: Tue, 07 Oct 2025 06:00:00 -0400
Authors: Huifeng Li, Tianle He, Dengjun Ma, Huanhuan Gong, Zhenguo Yang,
CONCLUSION: The global burden of PCOS among women of reproductive age has shown a consistent upward trend in incidence, prevalence, and DALYs. A comprehensive understanding of the epidemiology of PCOS among women of reproductive age is essential for informing targeted prevention strategies and optimizing disease control measures.
Published on: Tue, 07 Oct 2025 06:00:00 -0400
Authors: Xinkuo Zheng, Meishen Liu, Zhaohui Bai, Ling Wu, Lili Geng, Yun Shen, Jing Na, Haonan Qiu, Yalin Xi,